TipRanks
Go Ultimate55% OFF

Genmab (GMAB) Income Statement

Genmab Income Statement

Last quarter (Q2 2026), Genmab's total revenue was $1.16B, an increase of 24.89% from the same quarter last year. In Q2, Genmab's net income was $303.00M. See Genmab’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 3.72B$ 21.53B$ 16.47B$ 14.51B$ 8.42B
$ 3.41B$ 20.54B$ 16.25B$ 14.51B$ 8.42B
$ 2.16B$ 13.84B$ 10.93B$ 8.24B$ 5.46B
Depreciation and Amortization$ 71.06M$ 413.00M$ 293.62M$ 362.00M$ 248.99M
$ 1.34B$ 9.70B$ 6.00B$ 7.35B$ 4.18B
$ 1.25B$ 6.70B$ 5.32B$ 6.27B$ 2.95B
$ -46.04M$ 2.46B$ 316.00M$ 678.00M$ 965.00M
$ 1.20B$ 9.16B$ 5.64B$ 6.95B$ 3.92B
$ 963.76M$ 7.84B$ 4.35B$ 5.45B$ 2.96B
Per Share Metrics
Basic EPS$ 1.55$ 12.14$ 6.60$ 8.34$ 4.52
Diluted EPS$ 1.54$ 12.14$ 6.60$ 8.26$ 4.48
Weighted Average Shares Outstanding621.51M646.33M659.15M653.87M653.96M
Weighted Average Shares Outstanding (Diluted)626.92M646.33M659.15M660.10M660.46M

Currency in DKK

Genmab Earnings and Revenue History

08B16B24B20 %30 %40 %50 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin